This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Songy, W. B.
Right arrow Articles by Falkow, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Songy, W. B.
Right arrow Articles by Falkow, S.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, August 2002, p. 2913-2918, Vol. 40, No. 8
0095-1137/02/$04.00+0     DOI: 10.1128/JCM.40.8.2913-2918.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Identification of Streptococcus bovis Biotype I Strains among S. bovis Clinical Isolates by PCR

Wanda B. Songy,1,2 Kathryn L. Ruoff,3 Richard R. Facklam,4 Mary J. Ferraro,3 and Stanley Falkow1*

Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California 94305,1 Protein Design Labs, Inc., Fremont, California 94555,2 Clinical Microbiology Laboratories, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114,3 Centers for Disease Control, Atlanta, Georgia 303334

Received 31 January 2002/ Returned for modification 10 April 2002/ Accepted 24 April 2002

Streptococcus bovis causes 24% of all streptococcal infective endocarditis cases. There are many reports linking both S. bovis bacteremia and endocarditis with various forms of gastrointestinal disease (primarily colonic cancers). S. bovis is divided into two biotypes: I and II. The biotype I strain is much more frequently isolated from patients with endocarditis, gastrointestinal disease, or both. We describe here the isolation of biotype I-specific DNA sequences and the development of a PCR test which can identify S. bovis biotype I strains among S. bovis clinical isolates.

* Corresponding author. Mailing address: Department of Microbiology and Immunology, Sherman Fairchild Science Bldg., Rm. D039, 299 Campus Dr., Stanford, CA 94305-5124. Phone: (650) 725-4754. Fax: (650) 725-7282. E-mail: swfisher{at}stanford.edu.

Journal of Clinical Microbiology, August 2002, p. 2913-2918, Vol. 40, No. 8
0095-1137/02/$04.00+0     DOI: 10.1128/JCM.40.8.2913-2918.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Lee, R. A., Woo, P. C.Y., To, A. P.C., Lau, S. K.P., Wong, S. S.Y., Yuen, K.-Y. (2003). Geographical difference of disease association in Streptococcus bovis bacteraemia. J Med Microbiol 52: 903-908 [Abstract] [Full Text]  
  • Kurtovic, A., Jarvis, G. N., Mantovani, H. C., Russell, J. B. (2003). Ability of Lysozyme and 2-Deoxyglucose To Differentiate Human and Bovine Streptococcus bovis Strains. J. Clin. Microbiol. 41: 3951-3954 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»